July 10 (Reuters) - British drugmaker GSK said on Friday its experimental drug for treating patients with advanced or ...

By Bhanvi Satija and Prerna Bedi July 10 (Reuters) - GSK said on Friday that partner Hansoh Pharmaceutical's experimental ...

Understand the difference between targeted therapy, chemotherapy, and immunotherapy in lung cancer — and why starting the wrong treatment first can be harmful for patients with targetable mutations.

Targeted therapy is a form of precision medicine. We’ve been moving away over the last 10-15 years from conventional chemotherapy, which can be effective against certain cancers. But it carries lots ...

Approximately 25-30% of lung cancer patients lack mutations targeted by current therapies, necessitating novel approaches. New targets, including MTAP deletions, SMARC4, and p53 mutations, show ...

What Does Resistance to Targeted Therapy Mean? Targeted therapies for cancer are medicines designed to precisely target the protein that’s making your cancer grow. In the case of epidermal growth ...

A next-generation nanobody-liposome treatment slashes tumor growth by homing in on a key cancer marker, opening new doors for safer and more effective lung cancer therapy. Study: Targeting CD155 in ...

Targeted therapies are cancer medications that work more selectively than standard chemotherapy medications. They do this by targeting specific molecules or genetic changes in cancer cells in order to ...

Matthew Herper covers medical innovation — both its promise and its perils. The biotech firm Nuvalent said Tuesday that new data indicate its targeted drug zidesamtinib could help patients with a rare ...

In this interview with Targeted Oncology managing editor Sabrina Serani, Estelamari Rodriguez, MD, MPH, hematologist-oncologist at Sylvester Comprehensive Cancer Center, discusses ...

INDIANAPOLIS, Ind. (Ivanhoe Newswire) - Lung cancer is the leading cause of cancer deaths in the U.S., according to the American Cancer Society. For people battling a certain type of lung cancer, ...